+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific General Surgical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • PDF Icon


  • 78 Pages
  • April 2023
  • Region: Asia Pacific
  • Mordor Intelligence
  • ID: 5764522
The Asia-Pacific market for general surgical devices is expected to register a CAGR of 4.6% during the forecast period.

COVID-19 had a significant impact on the Asia-Pacific market for general surgical devices in the initial phases, as the surgeries and procedures were delayed due to global lockdowns. However, with the easing of restrictions, the industry rebounded strongly. Over the previous two years, the market recovery has been led by an increase in the sales of surgical devices, new product launches, and a high prevalence of injuries and accidents.

Factors such as the increasing demand for minimally invasive devices, cases of injuries and accidents, and healthcare expenditures in emerging economies are boosting the market's growth. For instance, as per the 2021 report published by the NCRB, Government of India, traffic accidents resulted in injuries to 3,73,884 persons in 2021. Furthermore, as per the WHS Statistics Australia 2022 report, 52,316 traumatic joint/ligament and muscle/tendon injuries were recorded in Australia in 2021. The main reason for injury hospitalization in Australia was found to be an accident or fall. Hence, considering the growing cases of injuries and accidents, the market for general surgical devices is expected to grow significantly.

The increasing healthcare expenditures in emerging economies and the adoption of minimally invasive devices for surgery are promoting the market growth. For instance, per the Parliament of Australia 2022 update, the total spending on healthcare in 2022-23 is estimated at USD 105.8 billion, representing 16.8% of the Australian government’s total expenditure. Moreover, as per the India Union Budget 2022-2023, the government allocated INR 86,200 crores (about USD 10.6 million) to the Ministry of Health and Family Welfare, a nearly 16.5% increase in comparison to INR 73,932 crores (about USD 10.4 billion) in 2021 driven by increased allocation to centrally sponsored public health schemes to continue building sustainable healthcare infrastructure and ensure system preparedness to handle the increasing healthcare needs of the country. Such increased healthcare expenditure and funding are expected to boost market growth over the forecast period. The growing burden of chronic diseases, along with the rising geriatric population in these countries, is likely to lead to increased demand for general surgical devices. Spending on healthcare in Asian countries is also expected to increase during the forecast period. For instance, according to the e-Stat, in Japan, households spent an average of around JPY 15,162 (USD 102.03) on medical treatments in 2022. Thus, the growing burden of diseases is expected to increase the demand for general surgical devices during the forecast period.

Hence, as per the factors mentioned above, the market studied is likely to witness growth over the forecast period. However, stringent government regulations and improper reimbursement for surgical devices restrain the market growth.

Asia-Pacific General Surgical Devices Market Trends

Handheld Devices is Expected to Dominate the General Surgical Devices Market Over the Forecast Period

In Asia-Pacific countries, the rising number of surgeries is leading to the increased usage of hand-held surgical devices. The development of advanced devices, like robotic hand-held surgical devices for laparoscopic interventions, enhances a surgeon’s dexterity. Needle holders are very similar in shape to hemostats, featuring jaws and handles. Needle holders allow the needle to be locked into place for suturing in a variety of tissue types.

The market is growing due to the rise in minimally invasive surgical procedures, increasing product launches, and an increase in outpatient surgeries. For instance, in November 2022, Venkateshwar hospital in India, with the support of Medtronic Private Limited, performed a urological procedure using the 'Hugo' robotic-assisted surgery (RAS) system in North India. Additionally, in February 2022, Smith+Nephew launched its next-generation handheld robotics platform, the CORI Surgical System, in Japan. Smith+Nephew's CORI Surgical System expands on the increasing adoption and long-term success of its NAVIO Surgical System in Japan.

The presence of competitors, mergers, acquisitions, and product launches promote market growth as these improve the chances of product availability as well as competition. For instance, in September 2022, researchers from the Indian Institute of Technology developed a simple and portable device to detect an ischemic stroke. This low-cost diagnostic technique is anticipated to help in precisely detecting ischemic stroke and can be used in rural, poor, and remote areas for early diagnosis.

Thus, the above-mentioned factors are expected to drive market growth.

India is Expected to Witness a Growth in the Studied Market Over the Forecast Period

India is expected to witness growth in the market studied owing to factors such as increasing cases of accidents and injuries, a rise in healthcare expenditure, and government funding for health and welfare. As per the 2021 report from NCRB, the major traffic accidents in India comprised 4,03,116 road accidents, 17,993 railway accidents, and 1,550 railway crossing accidents in 2021. Since accident cases in India are considerably high, which can cause severe injury and lead to hospitalization and surgery, the market for surgical devices is anticipated to witness growth.

The Indian government invests and funds more in health and welfare, which boosts the market for surgical devices, allowing hospitals and healthcare systems to afford and purchase more surgical devices. For instance, as per the India Union Budget 2022-2023, to strengthen blood transfusion services, a new allocation of INR 404 crores (about USD 49 million) was announced to develop hospital-based or stand-alone blood centers. As per the same source, allocated INR 5,156 crores (about USD 625.6 thousand) outlay as part of the PM Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) announced in October 2021 to strengthen health infrastructure at mission mode approach and improve primary, secondary, and tertiary care services.

The presence of competitors and product launches are the major drivers of market growth. For instance, in April 2021, Dolphin Sutures Company launched non-absorbable polytetrafluoroethylene sutures, TEFLENE. It is a monofilament, non-absorbable, extremely smooth suture material composed of a strand of polytetrafluoroethylene (PTFE). The company also expanded its product portfolio in India. Furthermore, in February 2022, Bengaluru-based Futura Surgicare Pvt Ltd launched Hemostatic products under the brand Hemostax (Oxidised Regenerated Cellulose) under a new vertical, Dolphin Hemostats. Hemostax Standard is an absorbable hemostat that is designed to help surgeons control bleeding more efficiently. Such increased product launches in India are promoting market growth over the forecast period.

Hence, as per the aforementioned factors, India is expected to witness growth in the market studied over the forecast period.

Asia-Pacific General Surgical Devices Market Competitor Analysis

The Asia-Pacific market for general surgical devices is fragmented because of the presence of many large, medium, and small players. Some of the major players are B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Medtronic PLC, and Johnson & Johnson, among others.

Additional benefits of purchasing the report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Devices
4.2.2 Growing Cases of Injuries and Accidents
4.2.3 Increasing Healthcare Expenditures in Emerging Economies
4.3 Market Restraints
4.3.1 Stringent Government Regulations
4.3.2 Improper Reimbursement for Surgical Devices
4.4 Porter Five Forces
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Product
5.1.1 Handheld Devices
5.1.2 Laparoscopic Devices
5.1.3 Electro Surgical Devices
5.1.4 Wound Closure Devices
5.1.5 Trocars and Access Devices
5.1.6 Other Products
5.2 By Application
5.2.1 Gynecology and Urology
5.2.2 Cardiology
5.2.3 Orthopedic
5.2.4 Neurology
5.2.5 Other Applications
5.3 Geography
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 Australia
5.3.5 South Korea
5.3.6 Rest of Asia-Pacific
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 B. Braun Melsungen AG
6.1.3 Conmed Corporation
6.1.4 Boston Scientific Corporation
6.1.5 Johnson & Johnson
6.1.6 Olympus Corporation
6.1.7 Stryker Corporation
6.1.8 Integer Holdings Corporation
6.1.9 Smith & Nephew PLC
6.1.10 Getinge AB (Maquet Holding BV & Co. KG)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic PLC
  • B. Braun Melsungen AG
  • Conmed Corporation
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Olympus Corporation
  • Stryker Corporation
  • Integer Holdings Corporation
  • Smith & Nephew PLC
  • Getinge AB (Maquet Holding BV & Co. KG)